Why is Kwality Pharma falling/rising?

As of 16-Jul, Kwality Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs 1,164.60, which reflects a decrease of Rs 29.5 or 2.47%. Today's price summary indicates that the stock underperformed its sector by 2.2%, touching an intraday low of Rs 1,160. The stock has shown strong performance over the past year, with a return of 134.14%, but it has also faced challenges, such as a decline in net sales and operating profit over the last five years. Despite positive indicators like a low debt to EBITDA ratio and consistent profit growth in recent quarters, the stock's valuation appears expensive compared to its peers, which may contribute to investor caution.
In the broader market context, the stock has outperformed the Sensex over various periods, including a 1-week return of 1.82% compared to the benchmark's -1.08%. However, the recent decline in investor participation, evidenced by a 12.78% drop in delivery volume, suggests a potential shift in market sentiment. While the stock has shown strong long-term growth, the lack of domestic mutual fund investment may indicate a lack of confidence among institutional investors, further influencing the stock's current downward movement.